NCT01156025 - Efficacy and Safety of GV 550 in Acute Adenovirus Keratoconjunctivitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

June 30, 2010

Conditions

Acute Adenoviral Keratoconjunctivitis

Interventions

DRUG

GV550

Ganciclovir 1.5 mg/g, 1 drop 10 times daily at D0 and D1 and 1 drop 5 times daily from D2 to D9 + additionnal treatment (Hyabak® eye drops: 5 times daily from D10 to D30)

DRUG

placebo

1 drop 10 times daily at D0 and D1 and 1 drop 5 times daily from D2 to D9 + additionnal treatment (Hyabak® eye drops: 5 times daily from D10 to D30)

Trial Locations (1)

63000

Medical Director, Clermont-Ferrand